Chronic exposure of transforming growth factor beta 1 confers a more aggressive tumor phenotype through downregulation of p21(WAF1/CIP1) in conditionally immortalized pancreatic epithelial cells.
暂无分享,去创建一个
M. Imamura | D. Ito | K. Kami | M. Koizumi | Tomohiko Mori | E. Toyoda | K. Fujimoto | R. Doi | R. Whitehead | Y. Kawaguchi
[1] M. Imamura,et al. Conditional transformation of mouse pancreatic epithelial cells: an in vitro model for analysis of genetic events in pancreatocarcinogenesis. , 2004, Biochemical and biophysical research communications.
[2] C. Arteaga,et al. Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases , 2002 .
[3] Allan Balmain,et al. TGF-β signaling in tumor suppression and cancer progression , 2001, Nature Genetics.
[4] H. Sheng,et al. Transforming Growth Factor-β1 Promotes Invasiveness after Cellular Transformation with Activated Ras in Intestinal Epithelial Cells , 2001 .
[5] P. Cotton,et al. Increased Transforming Growth Factor &bgr; in Pure Pancreatic Juice in Pancreatitis , 2001, Pancreas.
[6] A. Schulze,et al. Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. , 2000, Genes & development.
[7] L. Wakefield,et al. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells. , 1999, Cancer research.
[8] J. Hecht,et al. Immunohistochemical evaluation of K-ras, p53, and HER-2/neu expression in hyperplastic, dysplastic, and carcinomatous lesions of the pancreas: evidence for multistep carcinogenesis. , 1999, Human pathology.
[9] P. Isakson,et al. Transformation of intestinal epithelial cells by chronic TGF-β1 treatment results in downregulation of the type II TGF-β receptor and induction of cyclooxygenase-2 , 1999, Oncogene.
[10] P. P. Hu,et al. Molecular Mechanisms of Transforming Growth Factor-β Signaling , 1998 .
[11] T. Shimosegawa,et al. Expression of Transforming Growth Factor β1 (TGFβ1) and Its Receptors in Pancreatic Duct Cell Carcinoma and in Chronic Pancreatitis , 1998 .
[12] R H Hruban,et al. Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas. , 1998, The American journal of surgical pathology.
[13] H. Beug,et al. TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. , 1996, Genes & development.
[14] Allan Balmain,et al. TGFβ1 Inhibits the Formation of Benign Skin Tumors, but Enhances Progression to Invasive Spindle Carcinomas in Transgenic Mice , 1996, Cell.
[15] C. Moskaluk,et al. Homozygous deletion map at 18q21.1 in pancreatic cancer. , 1996, Cancer research.
[16] Xiao-Fan Wang,et al. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[17] H. Friess,et al. Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival , 1993 .
[18] M. Sporn,et al. Transforming growth factor-beta: biological function and chemical structure. , 1986, Science.